CRWD vs DHR: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
CrowdStrike Holdings, Inc. · Technology
$684.86
+33.0% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRWD has more upside to fair value
(+33.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWD |
DHR |
| Current Price |
$684.86 |
$177.17 |
| Fair Value Estimate |
$910.68 |
$192.90 |
| Upside to Fair Value |
+33.0%
|
+8.9%
|
| Market Cap |
$174.3B |
$125.4B |
| Forward P/E |
-3604.5x
|
34.1x
|
| EV / EBITDA |
509.7x
|
20.8x
|
| Price / Sales |
34.2x
|
5.1x
|
| Price / FCF |
120.1x
|
23.7x
|
| Revenue Growth YoY |
+25.6%
|
+3.7%
|
| Gross Margin |
75.0%
|
60.7%
|
| Operating Margin |
-3.9%
|
21.0%
|
| Return on Equity |
-0.6%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.83%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-native endpoint protection through its Falcon platform, which benefits from strong data network effects and is gaining market share against legacy competitors. The company exhibits high business quality with durable competitive advantages, strong revenue growth of 25.6% in the most recent quarter, and accelerating…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
CRWD |
DHR |
| Zone Low |
$683.01 |
$144.68 |
| Zone High |
$774.08 |
$163.97 |
| In Buy Zone? |
Yes
|
No
|